+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06761287

Study of Endoscopic Removal After Neoadjuvant Treatment in Patients With Locally Advanced Rectal Cancer to Improve Surgery Decisions

Led by Centre Hospitalier Universitaire Saint Pierre · Updated on 2025-05-30

20

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the role of endoscopic resection after neoadjuvant therapy in patients with locally advanced rectal cancer. This prospective, non-randomized trial aims to assess the feasibility, safety, and effectiveness of removing residual scar tissue or superficial neoplastic tissue following initial treatment. It also explores whether this approach can help guide patient selection for more extensive surgery, such as total mesorectal excision, or serve as a standalone treatment for limited residual disease. Eligible patients undergo endoscopic submucosal or intermuscular dissection using specialized equipment about two to eight weeks after completing neoadjuvant chemoradiotherapy. Close follow-up includes short-interval restaging with endoscopic re-evaluation four to eight weeks after the initial evaluation. Some patients may also undergo total mesorectal excision, which involves surgical removal of the rectum and surrounding tissue. Participants receive detailed assessments including pathology analysis of resected tissue within 15 days after the endoscopic procedure. Researchers monitor disease recurrence and survival outcomes for up to five years after treatment. Safety is closely tracked through procedure-related complication rates and adverse events occurring up to five years after the procedure. Tumor characteristics and molecular biomarkers are also studied during this follow-up period to better understand treatment impact.

CONDITIONS

Brief Title

Optimizing Patient Selection for Surgery Using Pathologic Analysis Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer

Research Team

M

Mariana Figueiredo

A

Amélie Deleporte

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here